Physician profile
Steve Laverson
NPI 1467443499
$2,130.46
in general payments reported to CMS, 2019-2025
14 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $223 · 2021: $607 · 2022: $229 · 2023: $153 · 2024: $458 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596 · Long Term Medical Supply Or Device Loan: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.50 |
| Long Term Medical Supply Or Device Loan | $132.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $606.20 | 2019-2022 | |
| Tela Bio, INC. | $227.61 | 2022-2024 | Ovitex 2s |
| Merz North America, INC. | $189.37 | 2020-2021 | |
| Motiva USA, LLC | $173.65 | 2024 | |
| Allergan, INC. | $158.78 | 2020-2021 | |
| Polynovo North America LLC | $152.78 | 2023 | |
| Cvrx, INC. | $142.11 | 2021 | |
| Integra Lifesciences Corporation | $132.92 | 2024 | Acell |
| Merck Sharp & Dohme LLC | $101.60 | 2019 | |
| Becton, Dickinson and Company | $97.22 | 2025 | Phasix Mesh |
| Innovation Technologies INC | $66.25 | 2022 | |
| Abbvie INC. | $51.86 | 2024 | |
| Stryker Corporation | $19.99 | 2025 | Medpor |
| Aroa Biosurgery Incorporated | $10.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Laverson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.